>
Israel strikes back at Iran: Explosions rock airbase in city linked to Tehran's nuke program...
Elon Musk Apologizes for Tesla's Severance Snafu, Assures Immediate Correction
The Ukraine / Gaza LIE Just Collapsed And Warmongers' Agenda EXPOSED
Trump Trial CHAOS, 2 Jurors ALREADY Seated Dismissed Over Bias w/Danielle D'Souza...
Blazing bits transmitted 4.5 million times faster than broadband
Scientists Close To Controlling All Genetic Material On Earth
Doodle to reality: World's 1st nuclear fusion-powered electric propulsion drive
Phase-change concrete melts snow and ice without salt or shovels
You Won't Want To Miss THIS During The Total Solar Eclipse (3D Eclipse Timeline And Viewing Tips
China Room Temperature Superconductor Researcher Had Experiments to Refute Critics
5 video games we wanna smell, now that it's kinda possible with GameScent
Unpowered cargo gliders on tow ropes promise 65% cheaper air freight
Wyoming A Finalist For Factory To Build Portable Micro-Nuclear Plants
Preclinical evidence suggests that short-term fasting and diets that mimic fasting can protect healthy cells against chemotherapy, while simultaneously rendering cancer cells more vulnerable to the treatment. However, clinical research evaluating the potential of short-term fasting in patients with cancer is still in its infancy.
This was shown in a new paper published last week in Nature: Communications by Dutch scientists from Leiden who looked at fasting-mimicking diets in patients undergoing chemotherapy for the most common form of breast cancer.
In the trial conducted by Dr. Judith Kroep and colleagues, 129 patients with HER2-negative stage II/III breast cancer followed either a fasting-mimicking diet or their regular diet for 3 days prior to and during neoadjuvant chemotherapy (treatment given as a first step to shrink a tumor before surgery).